Levodopa Best Choice for Initial Parkinson's Treatment
Medscape NeurologyHeadlines
The largest ever drug trial in Parkinson's disease found that levodopa beats dopamine agonists and monoamine oxidase type B inhibitors in terms of patient-reported mobility, quality of life, and other measures.
Medscape Medical News
Original Article: http://www.medscape.com/viewarticle/826523?src=rss
Júlio Pereira
www.weneuro.com
www.linkedin.com/in/juliommais
lattes.cnpq.br/7687651239699170
Consultório (11)3141-9550/3141-9553
No comments:
Post a Comment